How can developing countries harness biotechnology to improve health?
2007

Harnessing Biotechnology to Improve Health in Developing Countries

Sample size: 232 publication Evidence: moderate

Author Information

Author(s): Abdallah S. Daar, Kathryn Berndtson, Deepa L. Persad, Peter A. Singer

Primary Institution: McLaughlin-Rotman Centre for Global Health, University of Toronto

Hypothesis

How can developing countries harness biotechnology to improve health?

Conclusion

The recommendations from the courses provide guidance for developing countries to effectively utilize biotechnology and genomics to improve health outcomes.

Supporting Evidence

  • The courses involved 232 experts from 58 countries.
  • Recommendations were categorized into science, finance, ethics, society, culture, and politics.
  • The courses aimed to build a network for future collaboration in biotechnology.

Takeaway

This study shows that countries can work together to use biotechnology to help people stay healthy, especially in places where healthcare is not very good.

Methodology

The study involved organizing five courses with experts from various sectors in the developing world to generate recommendations on harnessing biotechnology for health.

Potential Biases

The process may have been influenced by the specific participants involved, potentially limiting the diversity of perspectives.

Limitations

The recommendations were based on opinions rather than formal consensus processes, which may affect their rigor.

Participant Demographics

Participants included government officials, scientists, industry executives, and members of NGOs from 58 countries.

Digital Object Identifier (DOI)

10.1186/1471-2458-7-346

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication